Orange Book product · Generic (ANDA)
AMOXICILLIN
AMOXICILLIN
At a glance
Jun 25, 2020
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 25, 2020
6 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
AMOXICILLIN
Strength
125MG
Dosage form
TABLET, CHEWABLE
Route
ORAL
TE code
Not listed
Application
ANDA 205274
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AMOXICILLIN
- 1999AMOXILBrand (NDA)
NDA 050760 · US ANTIBIOTICS
- —AMOXILBrand (NDA)
NDA 050459 · GLAXOSMITHKLINE
- —AMOXILBrand (NDA)
NDA 050460 · GLAXOSMITHKLINE
- 2022AMOXICILLINGeneric (ANDA)
ANDA 207471 · MICRO LABS
- 2014AMOXICILLINGeneric (ANDA)
ANDA 204030 · AUROBINDO PHARMA LTD
- 2007AMOXICILLINGeneric (ANDA)
ANDA 065319 · CHARTWELL RX
- 2007AMOXICILLINGeneric (ANDA)
ANDA 065387 · SANDOZ
- 2007AMOXICILLINGeneric (ANDA)
ANDA 065378 · SANDOZ
- 2007AMOXICILLINGeneric (ANDA)
ANDA 065291 · HIKMA PHARMS
- 2006AMOXICILLINGeneric (ANDA)
ANDA 065334 · AUROBINDO
- 2006AMOXICILLINGeneric (ANDA)
ANDA 065322 · HIKMA
- 2006AMOXICILLINGeneric (ANDA)
ANDA 065325 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
